QTNT News and Press, Quotient Limited From 02/22/22

JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the Cowen 42nd Annual Health Care Conference. As part of the conference, the Company ...

Quotient Limited (QTNT) Q3 2022 Earnings Conference Call February 8, 2022 08:00 ET Company Participants Ali Kiboro - Chief Financial Officer Manuel Mendez - Chief Executive Officer Conference Call Participants Josh Jennings - Cowen Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Pres...

Gainers: Haemonetics (NYSE:HAE) +13%. Second Sight Medical Products (NASDAQ:EYES) +8%. Catalyst Pharmaceuticals (NASDAQ:CPRX) +6%. Quotient (NASDAQ:QTNT) +5%. Ocuphire Pharma (NASDAQ:OCUP) +3%. Losers: Pulse Biosciences (NASDAQ:PLSE) -36%. Karyopharm Th...

Quotient press release (NASDAQ:QTNT): Q3 GAAP EPS of -$0.44 misses by $0.17. Revenue of $10.17M (+16.2% Y/Y) beats by $0.96M. Outlook for the Fiscal Year Ending March 31, 2022 The Company now expects that total product sales of Alba by Quotient reagents in the current fiscal year will be in t...

MosaiQ™ Solution: Transfusion Diagnostics: The Notified Body completed the assessment of the Company’s technical dossier and has advised that it will recommend the MosaiQ Expanded Immunohematology (IH) microarray for CE marking approval; Commercial Executio...

Quotient (NASDAQ:QTNT) is scheduled to announce FQ3 earnings results on Tuesday, February 8th, before market open. The consensus EPS Estimate is -$0.27 (+6.9% Y/Y) and the consensus Revenue Estimate is $9.21M (+5.3% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 0...

JERSEY, Channel Islands, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Confere...

The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22 First time attendance to Arab Health and Medlab Middle East 2022 in Dubai Generated traction on MosaiQ solution from potential distributors JERSEY, Channel Island...

JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022. ...

MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countries Quotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator...